Allyx Therapeutics, Inc. announced it raised $7.58 Million in an initial filing from an offering of $8.03 Million

Jun 02, 2021•over 4 years ago

Amount Raised

$7.58 Million

New HavenBiotechnology

Company Information

Company

Allyx Therapeutics, Inc.

Location

470 JAMES STREET

New Haven, Kentucky, United States

About

Synapse loss is the main driver of cognition loss in Alzheimer’s patients. Allyx Therapeutics develops products and therapies to reverse neuro-degeneration.

Allyx Therapeutics, Inc. announced it raised $7.58 Million in an initial filing from an offering of $8.03 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information